• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Swissmedic - Articles and news items

Alprolix approved in Switzerland for the treatment of haemophilia B

Industry news / 31 October 2016 / Niamh Louise Marriott, Digital Content Producer

The Swiss Agency for Therapeutic Products, Swissmedic, has approved Alprolix (eftrenonacog alfa) for the treatment of haemophilia B…

 

Webinar: NIR Spectroscopy for Assessing Blend Uniformity in the Pharmaceutical IndustryLEARN MORE
+ +